Feuerstein is full of it, IMO, for giving the Best Biotech CEO award to Meldrum of MYGN and honorable mention to JP Sommadossi of IDIX. I happen to think Sommadossi is about 50 times smarter than Meldrum, and IDIX vastly outperformed MYGN in 2008 to date.
IMCL’s Carl Icahn? No way—he wasn’t even a CEO.
2008 share-price performance to date IDIX +136% IMCL +63% MYGN +38%
News 
Market Data 
Discover 
